TALK WITH US.
WE’VE BEEN THERE.
We are prostate cancer survivors,
here to answer your prostate cancer questions.
Contact Us
Call: (505) 254-7784
(7 days/week)
Email: pchelp@pcsanm.org
Visit: 2533 Virginia St NE, Suite C Albuquerque, NM 87110
The office is open Monday through Thursday from 10 to 2.
Support by phone is available seven days a week.
Annual Conference
Our 13th annual conference was held on October 26, 2024. Check back for details about the 2025 conference!
MEETINGS
Our bi-weekly meetings held in person (some also an offer an option to attend virtually).
Newsletter
Check out the newsletter for the latest information on prostate cancer and resources.
Approximately 1 in 8 men will get prostate cancer.
PCSANM helps men and their families cope with this disease.
We offer:
- Publications and other reading materials on a wide variety of prostate cancer subjects
- Free one-on-one consultations for those diagnosed with prostate cancer and those dealing with the diagnosis of a loved one
- A list of survivors willing to discuss their treatment experience and side effects
- Bi-monthly support meetings including presentations by medical professionals expert in prostate cancer and related topics
- Outreach activities at conferences and health fairs
- Educational presentations to organizations
- Vouchers for free PSA tests for those who have no medical insurance, no primary care physician, or are experiencing troubling symptoms
We offer education, information, and support and will share our experiences with prostate cancer treatments and side effects.
What’s New
Advances in Prostate Cancer Radiation Oncology
This report is a review of recent and emerging trends that promise to make radiation oncology for prostate cancer more efficient, effective, and patient-friendly.
FDA Grants Fast Track Designation to 64Cu-SAR-bisPSMA PET Agent for Prostate Cancer
This could be a game changer in prostate cancer diagnosis.
Precision Drug Olaparib May Be Effective Without Hormone Therapy for Some Men with Biochemically Recurrent Prostate Cancer
Following treatment with olaparib, 13 participants, including all 11 who had BRCA2 mutations, had a decrease in PSA of at least 50% — a sign that their cancers were receding.
Would you like to support PCSANM?
Volunteer
Contact us to learn more
OUTREACH
Contact us to learn more
Donate
Help us unlock new possibilities in education and outreach for prostate cancer awareness.
How to Donate